Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reissue Patent
2008-04-29
2008-04-29
Morris, Patricia L. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S162000
Reissue Patent
active
10117634
ABSTRACT:
Tricyclic nitrogen containing compounds, having anxiolytic and anti-depressant activity and central nervous system activity of the following structural formula:and pharmaceutically acceptable salts thereof wherein R1and R2are independently hydrogen, C1-6alkyl or R1and R2are joined to form pyrrolidiae, piperidine, morpholine or imidazole. X is OCH3, SO2R3, SO2CF3or CN where R3is C1-6alkyl or an Aryl; and Y is hydrogen, Cl, Br, F, CN, CONR1R2, CF3, OCH3, SO2NR1R2. These new compounds are suitable for treating anxiolytic disorder, schizophrenia, Parkinson's disease, anxiety, depression or as compounds for lowering blood pressure or treating migraine headaches in patients in need of such treatment.
REFERENCES:
patent: 4110339 (1978-08-01), Bach et al.
patent: 5151431 (1992-09-01), Inaba et al.
patent: 3346573 (1985-07-01), None
patent: 153083 (1985-08-01), None
patent: 87/04153 (1987-07-01), None
patent: 88/04292 (1988-06-01), None
patent: 90/15058 (1990-12-01), None
Pohlke et al, “Heterocycles—substituted adenonines” CA 78:136628 (1973).
Glenn et al,II , “2,3-Dihydro and carbocyclis, etc” J.Med. Chem. 1982, 25, 68-70.
Glenn et al I, “2,3-Dihydro and carbocyclic, etc” CA 96:302 (1982).
Moon et al, “Synthesis of titium-labeled, etc” CA118:101872 (1993).
Kusudo et al, “N-Substituted 1,2,3-4-tetrahydroauinoline, etc” CA 65:107987 (1966).
Sotoda et al, “Synthesis of quinoline derivatives, etc” CA 62:9040 (1965).
Evans, D.D., Peters, D. J., J Chem. Soc. Perkin Trans. 1, pp. 285-288 (1974).
Morris Patricia L.
Pharmacia & Upjohn Company
Pharmacia & Upjohn Company
Wootton Thomas A.
LandOfFree
Heterocyclic amines having central nervous system activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic amines having central nervous system activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic amines having central nervous system activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3958447